EyePoint(EYPT)_个股概要_股票价格_最新资讯_行情走势_历史数据

EyePoint(EYPT)

盘后9.890.18+1.81%19:31 EDT

9.71+0.25+2.64%

社区社区
资讯资讯
资料资料
公告公告

- 最新
- 推荐
- Eyepoint Pharmaceuticals, Inc.盘中异动临近午盘大幅上涨5.08%
  自选股智能写手 · 07-25 23:59
  Eyepoint Pharmaceuticals, Inc.盘中异动临近午盘大幅上涨5.08%
- Eyepoint Pharmaceuticals, Inc.盘中异动临近午盘股价大跌5.22%
  自选股智能写手 · 07-18
  Eyepoint Pharmaceuticals, Inc.盘中异动临近午盘股价大跌5.22%
- Eyepoint Pharmaceuticals, Inc.盘中异动急速下挫5.05%
  自选股智能写手 · 07-03
  Eyepoint Pharmaceuticals, Inc.盘中异动急速下挫5.05%
- Eyepoint Pharmaceuticals, Inc.盘中异动临近午盘大幅下跌5.17%
  自选股智能写手 · 07-01
  Eyepoint Pharmaceuticals, Inc.盘中异动临近午盘大幅下跌5.17%
- Eyepoint Pharmaceuticals, Inc.盘中异动早盘快速上涨5.03%报9.19美元
  自选股智能写手 · 06-28
  Eyepoint Pharmaceuticals, Inc.盘中异动早盘快速上涨5.03%报9.19美元
- Eyepoint Pharmaceuticals, Inc.盘中异动下午盘快速跳水5.27%报8.23美元
  自选股智能写手 · 06-21
  Eyepoint Pharmaceuticals, Inc.盘中异动下午盘快速跳水5.27%报8.23美元
- Eyepoint Pharmaceuticals, Inc.盘中异动下午盘快速拉升5.10%
  自选股智能写手 · 06-06
  Eyepoint Pharmaceuticals, Inc.盘中异动下午盘快速拉升5.10%
- Eyepoint Pharmaceuticals, Inc.盘中异动早盘大幅下挫5.24%
  自选股智能写手 · 06-04
  Eyepoint Pharmaceuticals, Inc.盘中异动早盘大幅下挫5.24%
- Eyepoint Pharmaceuticals, Inc.盘中异动大幅下挫5.12%报10.56美元
  自选股智能写手 · 05-30
  Eyepoint Pharmaceuticals, Inc.盘中异动大幅下挫5.12%报10.56美元
- Eyepoint Pharmaceuticals, Inc.盘中异动早盘急速拉升5.40%报12.88美元
  自选股智能写手 · 05-14
  Eyepoint Pharmaceuticals, Inc.盘中异动早盘急速拉升5.40%报12.88美元
- HC Wainwright & Co.：维持EyePoint Pharmaceuticals(EYPT.US)评级，由买入调整至买入评级, 目标价由33.00美元调整至30.00美元。
  智通财经 · 05-13
  HC Wainwright & Co.：维持EyePoint Pharmaceuticals(EYPT.US)评级，由买入调整至买入评级, 目标价由33.00美元调整至30.00美元。
- Eyepoint Pharmaceuticals, Inc.盘中异动下午盘急速跳水5.05%报12.03美元
  自选股智能写手 · 05-11
  Eyepoint Pharmaceuticals, Inc.盘中异动下午盘急速跳水5.05%报12.03美元
- Eyepoint Pharmaceuticals, Inc.股价重挫29.53% 市值跌2.15亿美元
  自选股智能写手 · 05-06
  Eyepoint Pharmaceuticals, Inc.股价重挫29.53% 市值跌2.15亿美元
- Eyepoint Pharmaceuticals, Inc.盘中异动下午盘股价大涨5.35%
  自选股智能写手 · 05-03
  Eyepoint Pharmaceuticals, Inc.盘中异动下午盘股价大涨5.35%
- Eyepoint Pharmaceuticals, Inc.盘中异动下午盘快速拉升5.06%报18.49美元
  自选股智能写手 · 05-02
  Eyepoint Pharmaceuticals, Inc.盘中异动下午盘快速拉升5.06%报18.49美元
- Eyepoint Pharmaceuticals, Inc.盘中异动股价大涨5.01%报17.59美元
  自选股智能写手 · 04-30
  Eyepoint Pharmaceuticals, Inc.盘中异动股价大涨5.01%报17.59美元
- EyePoint Pharmaceuticals Inc 预计每股亏损 41 美分 - 财报前瞻
  Reuters · 04-29
  EyePoint Pharmaceuticals Inc 预计每股亏损 41 美分 - 财报前瞻
- Eyepoint Pharmaceuticals, Inc.盘中异动大幅上涨6.64%
  自选股智能写手 · 04-23
  Eyepoint Pharmaceuticals, Inc.盘中异动大幅上涨6.64%
- Eyepoint Pharmaceuticals, Inc.盘中异动早盘急速下挫5.68%
  自选股智能写手 · 04-18
  Eyepoint Pharmaceuticals, Inc.盘中异动早盘急速下挫5.68%
- Eyepoint Pharmaceuticals, Inc.盘中异动早盘股价大跌5.08%报21.31美元
  自选股智能写手 · 04-15
  Eyepoint Pharmaceuticals, Inc.盘中异动早盘股价大跌5.08%报21.31美元
公司概况
公司名称
EyePoint
所属市场
NASDAQ
成立日期
- -
员工人数
- -
办公地址
- -
公司网址
http://www.eyepointpharma.com
邮政编码
- -
联系电话
- -
联系传真
- -
公司概况
EyePoint Pharmaceuticals Inc.于2008年3月成为特拉华州公司。其前身，pSivida有限公司于2000年12月在西澳大利亚注册成立一家澳大利亚公司。 pSivida开发微小，缓释，药物输送的产品。该公司用于药物输送的产品，依其设计，几个月或几年中都可控制和稳定输送药物速率。pSivida公司专注于利用其核心技术平台，Durasert和BioSilicon治疗眼睛后部的慢性疾病。 pSivida目前有三个认可的产品和两个主要正在开发的候选产品，这些产品代表了连续几代的Durasert技术平台。 pSivida公司开发的四分之三用于治疗视网膜疾病的缓释装置，目前已获得美国或欧洲联盟（欧盟）的批准。
- 06-26
  重要事件披露
  Form 8-K - Current report
  Form 8-K - Current report
- 06-21
  重要事件披露
  Form 8-K - Current report
  Form 8-K - Current report
- 05-28
  重要事件披露
  Form 8-K - Current report
  Form 8-K - Current report
- 05-15
  关联方拟减持公告
  Form 144 - Report of proposed sale of securities
  Form 144 - Report of proposed sale of securities
- 05-09
  季度报告
  Form 10-Q - Quarterly report [Sections 13 or 15(d)]
  Form 10-Q - Quarterly report [Sections 13 or 15(d)]
- 05-08
  重要事件披露
  Form 8-K - Current report
  Form 8-K - Current report
- 05-06
  重要事件披露
  Form 8-K - Current report
  Form 8-K - Current report
- 05-01
  超过5%披露
  Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
  Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
- 04-30
  超过5%披露
  Form SC 13G - Statement of acquisition of beneficial ownership by individuals
  Form SC 13G - Statement of acquisition of beneficial ownership by individuals
- 03-08
  年度报告
  Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
  Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
- 03-07
  重要事件披露
  Form 8-K - Current report
  Form 8-K - Current report
- 03-04
  重要事件披露
  Form 8-K - Current report
  Form 8-K - Current report
- 02-14
  超过5%披露
  Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
  Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
- 02-13
  超过5%披露
  Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
  Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
- 02-07
  超过5%披露
  Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
  Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]